Copenhagen, Capital Region of Denmark, Denmark
At Fluidan, we help our customers transform their production from manual to fully automatic viscosity control and improve overall equipment efficiency. The RheoStream® process rheometer offers unmatched control and precision of in-process viscosity measurement, enabling a streamlining of your supply chain. Before co-founding and leading Fluidan, I have worked at DuPont Nutrition & Health, Novozymes, and Novo Nordisk. My chemical engineering background, a strong commercial focus, and more than 25 years in the biotech industry have resulted in a strong record of building a long-term sustainable business through innovation-based strategic partnerships. Throughout my career, I have developed and demonstrated competencies within the following areas: - Negotiation and Establishment of Strategic Partnerships and Alliances - Strategy Development, Execution, P&L Responsibility - Business Development, Due Diligence, M&A - B-2-B Marketing - Innovation Management - Chemistry and Industrial Biotechnology Education: M.Sc. Chemistry, Biotechnology from DTU - Technical University of Denmark and B.Com. Marketing at Copenhagen Business School. If you think we can collaborate in the future, you are very welcome to contact me: (m): +45 2374 5664 (e): [email protected]
Fluidan was founded in 2014 by the inventor of RheoStream®, Physicist Ph.D. Fridolin Okkels and CEO Anders L. Østergård. Fluidan set out to develop a robust and easy-to-use instrument, that would essentially operate as a “rheology sensor,” albeit in a bigger box than most common sensors. In 2018, RheoStream® obtained CE compliance, which allowed for a growing list of customer projects and sales in the target industries: Paint/Coatings, Household Care, and Personal Care. For more information, visit our website: https://fluidan.com/
Navinno helps navigating your innovation. Strategy, Business Planning, Innovation management, Partnering - with a focus on customer needs and customer dialogue
Driving strategy process in Enablers Division and developing strategy and portfolio management across the new “Nutrition & Health” Business (Danisco & Solae food ingredients businesses) Leading business development and acquisitions for Enablers Division Selected achievements: - Lead several conclusive acquisition projects including non-binding offers, due diligence and negotiations - Implemented Division strategy through well-defined process and priorities - Developed and implemented Innovation Portfolio Management based on clear stage-gate criteria and simplified business cases, supporting slimming of pipeline
Establishing Novozymes in a new business area through acquisitions Selected achievements: - Defined vision and goal for the business area, analysed market structure and assessed acquisition candidates (mostly in China)
Leading 2 out of Novozymes' 8 cross-functional business segment strategy groups: -> Strategy and alliance management of animal feed enzyme business in global alliance with DSM Nutritional Products -> Strategy, marketing and business development of a range of food enzyme segments Annual revenue about EUR 130 million Leading team of 7-10 managers across 3 continents with high level of team-spirit and collaboration Selected achievements: - Entered into collaboration agreements based on R&D projects with the Worlds two leading food companies - Lead portfolio analysis of the food enzyme area and implemented clear prioritizations through business goals and projects across marketing, sales and technical service - Maintained growth through global crisis by prioritizing areas that closed the gaps - Development and launch of a range of innovative enzyme products for animal feed, despite the very slow and complex innovation processes in the feed industry
Strategy and alliance management of animal feed enzyme business in global alliance. Leading innovation efforts in Feed Applications lab. Annual revenue 70-110 MEUR. Managing team of 12-14 managers, scientists, technicians. Selected achievements: - High growth of animal feed enzyme business. - Complete renegotiation of alliance agreement. - Joint strategy process with alliance partner laying the ground for current business development.